Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms

REFERENCES

• Johansen JS, Stoltenberg M, Hansen M, Florescu A, Horslev-Petersen K, Lorenzen I, Price PA: Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.Rheumatology38 :618– 626,1999 .
   PubMed Web of Science ®Google Scholar
• Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N: Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications.Clin Chem47 :418– 425,2001 .
   PubMed Web of Science ®Google Scholar
• Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.Clin Chem47 :444– 450,2001 .
   PubMed Web of Science ®Google Scholar
• Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM: Absence of diurnal variation of C-reactive protein levels in healthy human subjects.Clin Chem47 :426– 430,2001 .
   PubMed Web of Science ®Google Scholar
• Rifai N, Buring JE, Lee IM, Manson JE, Ridker PM: Is C-reactive protein specific for vascular disease in women?Ann Intern Med136 :529– 533,2002 .
   PubMedGoogle Scholar
• Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.New Engl J Med347 :1557– 1565,2002 .
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.New Engl J Med336 :973– 979,1997 .
   PubMed Web of Science ®Google Scholar
• Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project.Arterioscler Thromb Vasc Biol17 :1121– 1127,1997 .
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N Engl J Med342 :836– 843,2000 .
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.Circulation99 :237– 242,1999 .
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.BMJ321 :199– 204,2000 .
   PubMed Web of Science ®Google Scholar
• Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC: C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.Eur Heart J21 :1584– 1590,2000 .
   PubMed Web of Science ®Google Scholar
• Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study.Stroke32 :2575– 2579,2001 .
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH: Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey.Arterioscler Thromb Vasc Biol20 :1052– 1056,2000 .
   PubMed Web of Science ®Google Scholar
• Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM: Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.Circulation105 :2595– 2599,2002 .
   PubMed Web of Science ®Google Scholar
• Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.JAMA285 :2481– 2485,2001 .
   PubMed Web of Science ®Google Scholar
• Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC: Inhibition of interleukin-1 synthesis by tenidap: a new drug for arthritis.Cytokine3 :227– 228,1991 .
   Google Scholar
• Sipe JD, Bartle MN, Loose LD: Modification of the proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen.J Immunol148 :480– 484,1992 .
   PubMed Web of Science ®Google Scholar
• Loose LD, de Oliveira R, Sipe JD, Franzblau C, Shanahan WR: A possible systemic component of osteoarthritis: elevated concentrations (by ELISA) of C reactive protein in serum of OA patients and modulation by tenidap.Arthritis Rheum39(Suppl) :S166 ,1996 .
   Google Scholar
• Loose LD, Sipe JD, Kirby DS, Kraska AR, Weiner ES, Shanahan WR, Leeming MR, Farrow P, Stack CB, Ting N: Reduction of acute-phase proteins with tenidap, a cytokine modulating antirheumatic drug.Br J Rheumatol32(Suppl 3) :19– 25,1993 .
   PubMedGoogle Scholar
• Johansen JS, Baslund B, Garbasch C, Hansen M, Lorenzen I, Price PA: YKL-40 in giant cells and macrophages from patients with giant cell arteritis.Arthritis Rheum42 :2624– 2630,1999 .
   PubMed Web of Science ®Google Scholar
• Johansen JS, Moller S, Price PA, Bendtsen F, Junge J, Garbarsch C, Henriksen JH: Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?Scand J Gastroenterol32 :582– 590,1997 .
   PubMed Web of Science ®Google Scholar
• Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB: Low-level increases in serum C reactive protein are present in early osteoarthritis of the knee and predict progressive disease.Arthritis Rheum40 :723– 727,1997 .
   PubMed Web of Science ®Google Scholar
• Conrozier Th, Carkier M-C, Mathieu P: Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.Ann Rheum Dis59 :828– 831,2000 .
   PubMed Web of Science ®Google Scholar
• Conrozier T, Chappuis-Cellier C, Richard M, Mathieu P, Richard S, Vignon E: Increased serum-C-reactive protein levels by immunonephelometry in patients with rapidly destructive osteoarthritis.Rev Rhum Engl Ed65 :759– 765,1998 .
   PubMedGoogle Scholar
• Wolfe F: The C reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip.J Rheumatol24 :1486– 1488,1997 .
   PubMed Web of Science ®Google Scholar
• Johansen JS, Jensen HS, Price PA: A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.Br J Rheumatol32 :949– 955,1993 .
   PubMedGoogle Scholar
• Hakala BE, White C, Recklies AD: Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of chitinase protein family.J Biol Chem268 :25803– 25810,1993 .
   PubMed Web of Science ®Google Scholar
• Nyirkos P, Golds EE: Human synovial cells secrete a 39 kD protein similar to a bovine mammary protein expressed during the non-lactating period.Biochem J268 :265– 268,1993 .
   Google Scholar
• Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ: Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.Free Radic Biol Med35 :772– 781,2003 .
   PubMed Web of Science ®Google Scholar
• Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB: Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women.Circulation108 :155– 160,2003 .
   PubMed Web of Science ®Google Scholar
• James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production.Am J Clin Nutr71 :343S– 348S,2000 .
   PubMed Web of Science ®Google Scholar
• Calder PC: N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?Nutr Res21 :309– 341,2001 .
   Web of Science ®Google Scholar
• Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J: Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.Circulation103 :2531– 2534,2001 .
   PubMed Web of Science ®Google Scholar
• Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.Circulation102 :2284– 2299,2000 .
   PubMed Web of Science ®Google Scholar
• Paschos GK, Rallidis LS, Liakos GK, Panagiotakos D, Anastasiadis G, Votteas V, Zampelas A: Background diet influences the anti-inflammatory effect of alpha-linolenic acid in dyslipidaemic subjects.Br J Nutr92 :649– 655,2004 .
   PubMed Web of Science ®Google Scholar
• Zampelas A, Paschos G, Rallidis L, Yiannakouris N: Linoleic acid to alpha-linolenic acid ratio. From clinical trials to inflammatory markers of coronary artery disease.World Rev Nutr Diet92 :92– 108,2003 .
   PubMedGoogle Scholar
• Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A: Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients.Atherosclerosis167 :237– 242,2003 .
   PubMed Web of Science ®Google Scholar
• Hirata F, Axelrod J: Phospholipid methylation and biological signal transmission.Science209 :1082– 1090,1980 .
   PubMed Web of Science ®Google Scholar
• Vanderhoek JY, Bryant RW, Bailey JM: Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.J Biol Chem255 :10064– 10066,1980 .
   PubMed Web of Science ®Google Scholar
• Naguib YM: Antioxidant activities of astaxanthin and related carotenoids.J Agric Food Chem48 :1150– 1154,2000 .
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA: Flavonoids: a review of probable mechanisms of action and potential applications.Am J Clin Nutr74 :418– 425,2001 .
   PubMed Web of Science ®Google Scholar
• Kazuhiro O, Kenji S, Satoshi K: Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo.Invest Ophthalmol Vis Sci44 :2694– 2701,2003 .
   PubMed Web of Science ®Google Scholar
• Horrobin DF: The role of essential fatty acids and prostaglandins in the premenstrual syndrome.J Reprod Med28 :465– 468,1983 .
   PubMed Web of Science ®Google Scholar
• Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development.Am J Clin Nutr54 :438– 463,1991 .
   PubMed Web of Science ®Google Scholar
• Drevon CA: Marine oils and their effects.Nutr Rev50 :38– 45,1992 .
   PubMed Web of Science ®Google Scholar
• Hansen HS: Dietary essential fatty acids and in vivo prostaglandin production in mammals.World Rev Nutr Diet42 :102– 134,1983 .
   PubMedGoogle Scholar
• Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.New Engl J Med320 :265– 271,1989 .
   PubMed Web of Science ®Google Scholar
• Hansen HS, Olsen SF: Dietary (n-3)-fatty acids, prostaglandins and prolonged gestation in humans.Prog Clin Biol Res282 :305– 317,1988 .
   PubMedGoogle Scholar
• Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF: Effects of exogenous arachidonic, eicosapentaenoic and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.J Clin Invest74 :1922– 1933,1984 .
   PubMed Web of Science ®Google Scholar
• Deutch B: Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake.Eur J Clin Nutr49 :508– 516,1995 .
   PubMed Web of Science ®Google Scholar
• Deutch B: Painful menstruation and low intake of n-3 fatty acids.Ugeskr Laeger158 :4195– 4198,1996 .
   PubMedGoogle Scholar
• Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL: Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents.Am J Obstet Gynecol174 :1335– 1338,1996 .
   PubMed Web of Science ®Google Scholar
• Hutchison R: COX-2 selective NSAIDs.Am J Nurs104 :16 ,2004 .
   Google Scholar
• Barton LL: Nonsteroidal anti-inflammatory drugs and invasive staphylococcal infections: the cart or the horse?Pediatrics115 :1790 , author reply 1791,2005 .
   PubMedGoogle Scholar
• Sudbo J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimaki A, Sudbo A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ: Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study.Lancet366 :1359– 1366,2005 .
   PubMed Web of Science ®Google Scholar
• Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM: Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study.Arthritis Rheum52 :3137– 3142,2005 .
   PubMed Web of Science ®Google Scholar
• Messerli FH, Sichrovsky T: Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?Am J Cardiol96 :872– 873,2005 .
   PubMedGoogle Scholar
• Bennett JS, Daugherty A, Herrington D, Greenland P, Roberts H, Taubert KA: The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association.Circulation111 :1713– 1716,2005 .
   PubMedGoogle Scholar
• Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators: The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.Arch Intern Med165 :161– 168,2005 .
   PubMed Web of Science ®Google Scholar
• Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, VIGOR Study Group: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.New Engl J Med343 :1520– 1528,2003 .
   Google Scholar
• Salaffi F, Leardini G, Canesi B, Mannoni A, Fioravanti A, Caporali R, Lapadula G, Punzi L, GOnorthrosis and Quality Of Life Assessment (GOQOLA): Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee.Osteoarthritis Cartilage11 :551– 560,2003 .
   PubMed Web of Science ®Google Scholar
• Jinks C, Jordan K, Croft P: Measuring the population impact of knee pain and disability with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).Pain100 :55– 64,2002 .
   PubMed Web of Science ®Google Scholar
• Angst F, Aeschlimann A, Steiner W, Stucki G: Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention.Ann Rheum Dis60 :834– 840,2001 .
   PubMed Web of Science ®Google Scholar
• Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.J Rheumatol24 :799– 802,1997 .
   PubMed Web of Science ®Google Scholar
• Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD: Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure.J Orthop Sports Phys Ther28 :88– 96,1998 .
   PubMed Web of Science ®Google Scholar
• Mazzuca SA, Brandt KD, Katz BP, Dittus RS, Freund DA, Lubitz R, Hawker G, Eckert G: Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee.Arthritis Care Res10 :289– 299,1997 .
   PubMed Web of Science ®Google Scholar
• Martin DP, Engelberg R, Agel J, Swiontkowski MF: Comparison of the musculoskeletal function assessment questionnaire with the short form-36, the Western Ontario and McMaster Universities Osteoarthritis Index, and the Sickness Impact Profile health-status measures.J Bone Joint Surg79-A :1323– 1335,1997 .
   Google Scholar
• Bellamy N, Kean WF, Buchanan WW, Gerecz-Simon E, Campbell J: Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): postvalidation reapplication of the WOMAC Osteoarthritis Index.J Rheumatol19 :153– 159,1992 .
   PubMed Web of Science ®Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW: Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.J Rheumatol15 :1833– 1840,1988 .
   PubMed Web of Science ®Google Scholar
• Kreibich DN, Vaz M, Bourne RB, Rorabeck CH, Kim P, Hardie R, Kramer J, Kirkley A: What is the best way of assessing outcome after total knee replacement?Clin Orthop331 :221– 225,1996 .
   PubMed Web of Science ®Google Scholar
• Barr S, Bellamy N, Buchanan WW, Chalmers A, Ford PM, Kean WF, Kraag GR, Gerecz-Simon E, Campbell J: A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index.J Rheumatol21 :2106– 2112,1994 .
   PubMed Web of Science ®Google Scholar
• Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R: The effect of elective total hip replacement on health-related quality of life.J Bone Joint Surg75-A :1619– 1626,1993 .
   Google Scholar
• Slemenda C, Brandt KD, Heilman DK, Mazzuca S, Braunstein EM, Katz BP, Wolinsky FD: Quadriceps weakness and osteoarthritis of the knee.Ann Intern Med127 :97– 104,1997 .
   PubMed Web of Science ®Google Scholar
• Stucki G, Sangha O, Stucki S, Michel BA, Tyndall A, Dick W, Theiler R: Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis.Osteoarthritis Cartilage6 :79– 86,1998 .
   PubMed Web of Science ®Google Scholar
• McGrory BJ, Harris WH: Can the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index be used to evaluate different hip joints in the same patient?J Arthroplasty11 :841– 844,1996 .
   PubMedGoogle Scholar
• Bellamy N: “WOMAC Osteoarthritis Index: A User's Guide.” London, Ontario: McMaster University,1995 .
   Google Scholar